Unlike AML1, CBFβ gene is not deregulated by point mutations in acute myeloid leukemia and in myelodysplastic syndromes

Blood

Volumn 99, Issue 10, 2002, Pages 3848-3850

  Leroy, Hugues ^a,b,c   Roumier, Christophe ^a,b,c   Grardel Duflos, Nathalie ^a,b,c   Macintyre, Elizabeth ^a,b,c   Lepelley, Pascale ^a,b,c   Fenaux, Pierre ^a,b,c   Preudhomme, Claude ^a,b,c  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b Institut de Recherche sur le Cancer de Lille   (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CORE BINDING FACTOR; PROTEIN; PROTEIN AML 1; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; ONCOPROTEIN; RUNX1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 2; TRANSCRIPTION FACTOR RUNX1;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CLINICAL ARTICLE; EXON; GENE MUTATION; HUMAN; MYELODYSPLASTIC SYNDROME; PATHOGENESIS; POINT MUTATION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; ACUTE DISEASE; GENE EXPRESSION REGULATION; GENETICS; MYELOID LEUKEMIA;

ACUTE DISEASE; CORE BINDING FACTOR ALPHA 2 SUBUNIT; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HUMANS; LEUKEMIA, MYELOID; MYELODYSPLASTIC SYNDROMES; POINT MUTATION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROTO-ONCOGENE PROTEINS; TRANSCRIPTION FACTOR AP-2; TRANSCRIPTION FACTORS;

EID: 0037092550     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V99.10.3848     Document Type: Article

References (17)

1. Leukaemia/Drosophila homology
2. Role of the transcription factor AML-1 in acute leukemia and hematopoietic differentiation
3. The CBFβ sub-unit is essential for CBFα2 (AML1) function in vivo
4. AML1, the target of multiple chromosomal translocations In human leukemia, is essential for normal fetal liver hematopoiesis
5. AML1/CBFβ transcription complex: Its role in normal hematopoiesis and leukemia
6. Core-binding factor: A central player in hematopoiesis and leukemia
7. Leukemogenesis by CBF oncoproteins
8. The t(8;21) fusion product, AML-1-ETO, associates with C/EBP-alpha, inhibits C/EBP-alpha-dependent transcription, and blocks granulocytic differentiation
9. ETV6 is the target of chromosome 12p deletions in t(12; 21) childhood acute lymphocytic leukemia
10. The EVI1 gene in myeloid leukemia
11. MDS1/EVI1 enhances TGF-beta1 signaling and strengthens its growth-inhibitory effect but the leukemia-associated fusion protein AML1/MDS1/EVI1, product of the t(3;21), abrogates growth-inhibition in response to TGF-beta1
12. Transforming properties of the leukemic inv(16) fusion gene CBFBMYH11
13. Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopolesis
14. Biallelic and heterozygous point mutations in the runt domain of the AML1/PEBP2alphaB gene associated with myeloblastic leukemias
15. Mutations of the AML1 gene in myelodysplastic syndrome and their functional implications in leukemegenesis
16. High incidence of biallelic point mutations in the Runt domain of the AML1/PEBP2 alpha B gene in Mo acute myeloid leukemia and in myeloid malignancies with acquired trisomy 21
17. Proposals for the classification of the acute leukaemias: French-American-British (FAB) co-operative group